{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:51:45Z","timestamp":1771599105558,"version":"3.50.1"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.clindermatol.2004.06.012","type":"journal-article","created":{"date-parts":[[2005,3,30]],"date-time":"2005-03-30T12:19:15Z","timestamp":1112185155000},"page":"171-181","source":"Crossref","is-referenced-by-count":121,"title":["Life-threatening acute adverse cutaneous drug reactions"],"prefix":"10.1016","volume":"23","author":[{"given":"Ronni","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Orion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batsheva","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Matz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2004.06.012_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","article-title":"Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention","volume":"228","author":"Hallas","year":"1990","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/106002809302700702","article-title":"Drug-related hospital admissions","volume":"27","author":"Einarson","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib5","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.256.24.3358","article-title":"Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib6","first-page":"223","article-title":"Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985)","volume":"69","author":"Alanko","year":"1989","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archfami.1.2.241","article-title":"Dermatologic adverse drug reactions in a family medicine setting","volume":"1","author":"Ives","year":"1992","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0738-081X(93)90154-5","article-title":"Erythema multiforme (\u201cminus\u201d and \u201cmaius\u201d) and drug intake","volume":"11","author":"Fabbri","year":"1993","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","article-title":"A new eruptive fever associated with stomatitis and ophthalmia","volume":"24","author":"Stevens","year":"1922","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bmj.1.4667.1393","article-title":"The so-called Stevens-Johnson syndrome","volume":"1","author":"Thomas","year":"1950","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0738-081X(93)90155-6","article-title":"Drug-induced toxic epidermal necrolysis: I. An overview","volume":"11","author":"Lyell","year":"1993","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib13","first-page":"715","article-title":"The rediscovery of previously described dermatoses","volume":"137","author":"Tomb","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib14","first-page":"3","article-title":"Die exfoliateve Dermatitis jungerer Sauglinge","volume":"2","author":"Ritter von Rittershain","year":"1878","journal-title":"Centralzeit Kinderheilk"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib15","first-page":"231","article-title":"Un cas d'erythrodermie avec epidermolyse chez un enfant de 12 ans","volume":"37","author":"Debre","year":"1939","journal-title":"Bull. Soc. Pediatr. Paris"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.129.1.92","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0025-7125(16)31573-5","article-title":"Toxic epidermal necrolysis","volume":"64","author":"Rasmussen","year":"1980","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0140-6736(91)90273-R","article-title":"Intestinal involvement in drug-induced toxic epidermal necrolysis","volume":"337","author":"Chosidow","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF01706425","article-title":"Bronchopulmonary distress associated with toxic epidermal necrolysis","volume":"18","author":"Timsit","year":"1992","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib20","first-page":"113","article-title":"Hematologic anomalies in Lyell's syndrome. Study of 26 cases","volume":"110","author":"Bombal","year":"1983","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.127.5.739","article-title":"Severe hypothermia occurring during the course of toxic epidermal necrolysis in patients treated with air-fluidized beds","volume":"127","author":"Timsit","year":"1991","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF01690779","article-title":"Hypothermia and air-fluidized beds during toxic epidermal necrolysis management","volume":"17","author":"Timsit","year":"1991","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000070938","article-title":"Dermatological and ophthalmological sequels in toxic epidermal necrolysis","volume":"207","author":"Magina","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00406477","article-title":"Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis","volume":"277","author":"Roujeau","year":"1985","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2133.1986.tb02806.x","article-title":"Haematological disturbances and immune mechanisms in toxic epidermal necrolysis","volume":"114","author":"Goens","year":"1986","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1979.tb05580.x","article-title":"Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome)","volume":"100","author":"Kvasnicka","year":"1979","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-4362.1998.00490.x","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia","volume":"37","author":"Kamaliah","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archderm.129.6.792","article-title":"Hyperamylasemia in toxic epidermal necrolysis","volume":"129","author":"Chosidow","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(96)90297-2","article-title":"Renal involvement in toxic epidermal necrolysis","volume":"34","author":"Blum","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib32","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809040-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archsurg.1978.01370180100019","article-title":"Burn unit management of toxic epidermal necrolysis","volume":"113","author":"Demling","year":"1978","journal-title":"Arch. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib36","series-title":"Recent advances in dermatology","first-page":"85","article-title":"Intensive care in dermatology","author":"Roujeau","year":"1990"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib37","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00006534-197861060-00021","article-title":"Toxic epidermal necrolysis. Case report","volume":"61","author":"Anhalt","year":"1978","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2340\/0001555553149152","article-title":"Fifteen cases of toxic epidermal necrolysis (Lyell)","volume":"53","author":"Bjornberg","year":"1973","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib40","first-page":"204","article-title":"Toxic epidermal necrolysis and Stevens-Johnson's disease","volume":"46","author":"Ohlenschlaeger","year":"1966","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0190-9622(85)80012-8","article-title":"Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid \u201cpulse therapy\u201d","volume":"12","author":"Sherertz","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1378\/chest.98.2.331","article-title":"Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy","volume":"98","author":"Patterson","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","article-title":"Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"115","author":"Prendiville","year":"1989","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000248010","article-title":"Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories","volume":"180","author":"Tegelberg-Stassen","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2500\/108854192778878926","article-title":"Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS","volume":"13","author":"Patterson","year":"1992","journal-title":"Allergy Proc."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2500\/108854195778666793","article-title":"The outcome of Stevens-Johnson syndrome treated with corticosteroids","volume":"16","author":"Cheriyan","year":"1995","journal-title":"Allergy Proc."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.1976.tb00824.x","article-title":"Erythema multiforme in children. Response to treatment with systemic corticosteroids","volume":"95","author":"Rasmussen","year":"1976","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archderm.111.9.1135","article-title":"Toxic epidermal necrolysis. A review of 75 cases in children","volume":"111","author":"Rasmussen","year":"1975","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004630-198305000-00005","article-title":"A burn center experience with toxic epidermal necrolysis","volume":"4","author":"Halebian","year":"1983","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3468(89)80240-4","article-title":"Drug-induced toxic epidermal necrolysis in children","volume":"24","author":"Jones","year":"1989","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.me.40.020189.001033","article-title":"Burn unit treatment of acute, severe exfoliating disorders","volume":"40","author":"Halebian","year":"1989","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib53","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen","year":"1995","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","article-title":"Management of severe toxic epidermal necrolysis in children","volume":"20","author":"Sheridan","year":"1999","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib55","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000051702","article-title":"Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience","volume":"203","author":"Stella","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2002.127249","article-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children","volume":"47","author":"Tristani-Firouzi","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2230.2003.01255.x","article-title":"Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins","volume":"28","author":"Tan","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000070957","article-title":"Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study","volume":"207","author":"Prins","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami experience","volume":"139","author":"Trent","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1742-1241.2003.tb10578.x","article-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin","volume":"57","author":"Sidwell","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneurpsyc.1939.02270240091005","article-title":"Sodium diphenylhydantoinate in treatment of convulsive disorders: toxic symptoms and their prevention","volume":"42","author":"Merrit","year":"1939","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib66","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib67","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.29.11.1480","article-title":"Phenytoin hypersensitivity: 38 cases","volume":"29","author":"Haruda","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archderm.117.1.38","article-title":"Dapsone hypersensitivity. The sulfone syndrome revisited","volume":"117","author":"Tomecki","year":"1981","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib69","first-page":"166","article-title":"Methyldopa hypersensitivity syndrome","volume":"71","author":"Wolf","year":"1993","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib70","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.132.8.934","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib71","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug eruption with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib72","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.1998.tb01678.x","article-title":"Antiepileptic drug hypersensitivity syndrome","volume":"39","author":"Schlienger","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11882-002-0035-9","article-title":"Antiepileptic hypersensitivity syndrome: clinicians beware and be aware","volume":"2","author":"Bessmertny","year":"2002","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00005792-199505000-00004","article-title":"Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature","volume":"74","author":"De Vriese","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib77","first-page":"9","article-title":"Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis","volume":"15","author":"Cribb","year":"1996","journal-title":"Adverse Drug React. Toxicol. Rev."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2230.1998.00311.x","article-title":"Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol","volume":"23","author":"Hamanaka","year":"1998","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib79","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.162.10.1190","article-title":"Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus","volume":"162","author":"Sommers","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib80","first-page":"347","article-title":"Rare adverse reactions to nonsteroidal antiinflammatory drugs","volume":"12","author":"O'Brien","year":"1985","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1440-1746.1991.tb00899.x","article-title":"Cholestatic jaundice associated with captopril therapy","volume":"6","author":"Crantock","year":"1991","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib82","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/313475","article-title":"Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy","volume":"29","author":"Baylor","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib83","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1093\/clinids\/5.Supplement_3.S440","article-title":"Adverse effects of rifampin","volume":"5","author":"Grosset","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib84","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9343(00)00724-5","article-title":"Hypersensitivity syndrome associated with azithromycin","volume":"110","author":"Cascaval","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1034\/j.1600-0536.2001.450516.x","article-title":"Hypersensitivity syndrome from isoniazid with positive patch test","volume":"45","author":"Rebollo","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0190-9622(98)70241-5","article-title":"The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature","volume":"38","author":"Knowles","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200304010-00003","article-title":"Adverse cutaneous reactions to mood stabilizers","volume":"4","author":"Warnock","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib88","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000441-200102000-00008","article-title":"A case report of olanzapine-induced hypersensitivity syndrome","volume":"321","author":"Raz","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archderm.1981.01650010044023","article-title":"Dapsone hypersensitivity. The sulfone syndrome revisited","volume":"117","author":"Tomecki","year":"1981","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1440-0960.1998.tb01275.x","article-title":"Hypersensitivity syndrome reaction to oral terbinafine","volume":"39","author":"Gupta","year":"1998","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib91","first-page":"166","article-title":"Methyldopa hypersensitivity syndrome","volume":"71","author":"Wolf","year":"1993","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1067\/mjd.2002.119105","article-title":"Cutaneous manifestations of antiretroviral therapy","volume":"46","author":"Ward","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib93","first-page":"364","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"13","author":"Kennebeck","year":"2000","journal-title":"J. Am. Board Fam. Pract."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib94","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1468-3083.2003.00750.x","article-title":"The anticonvulsant hypersensitivity syndrome","volume":"17","author":"Baba","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib95","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1542\/peds.107.1.e14","article-title":"Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin","volume":"107","author":"Scheuerman","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib96","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0006-2952(95)02009-8","article-title":"Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity","volume":"50","author":"Green","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib97","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1440-1746.1991.tb00899.x","article-title":"Cholestatic jaundice associated with captopril therapy","volume":"6","author":"Crantock","year":"1991","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/WNL.29.2.175","article-title":"Phenytoin hepatotoxicity: a case report and review","volume":"29","author":"Parker","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib99","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0749-0704(05)70366-3","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"13","author":"Morkunas","year":"1997","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/pgmj.75.890.734","article-title":"Fatal phenytoin hypersensitivity syndrome","volume":"75","author":"Mahadeva","year":"1999","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib101","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1001\/archinte.155.21.2285","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"155","author":"Vittorio","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib102","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/ajkd.2000.19107","article-title":"Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment","volume":"36","author":"Fervenza","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5414\/CNP57310","article-title":"Carbamazepine-induced acute granulomatous interstitial nephritis","volume":"57","author":"Hegarty","year":"2002","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/106002808802201010","article-title":"Carbamazepine-induced severe systemic hypersensitivity reaction with eosinophilia","volume":"22","author":"Robbie","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1528-1157.2001.33400.x","article-title":"Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug","volume":"42","author":"Klassen","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1528-1157.1992.tb02293.x","article-title":"Carbamazepine-induced eosinophilic colitis","volume":"33","author":"Anttila","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib107","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1528-1157.1999.tb01598.x","article-title":"Colitis may be part of the antiepileptic drug hypersensitivity syndrome","volume":"40","author":"Eland","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1651-2227.1984.tb09948.x","article-title":"Acute interstitial pneumonitis and carbamazepine therapy","volume":"73","author":"De Swert","year":"1984","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib109","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1183\/09031936.93.06091409","article-title":"Acute interstitial pneumonitis induced by carbamazepine","volume":"6","author":"Takahashi","year":"1993","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0190-9622(98)70463-3","article-title":"Carbamazepine-induced pseudolymphoma with CD-30 positive cells","volume":"38","author":"Nathan","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib111","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","article-title":"Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection","volume":"148","author":"Descamps","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1054-8807(00)00049-1","article-title":"Giant cell myocarditis as a manifestation of drug hypersensitivity","volume":"9","author":"Daniels","year":"2000","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib113","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10194","article-title":"Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome","volume":"51","author":"Fujino","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib114","first-page":"1321","article-title":"DRESS (drug eruption with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy","volume":"27","author":"Bourezane","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00365540152029990","article-title":"Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy","volume":"33","author":"Lanzafame","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib116","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0029-7844(02)02620-0","article-title":"Drug eruption with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus","volume":"101","author":"Knudtson","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib117","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.32.11.1317","article-title":"Phenytoin-induced arthritis","volume":"32","author":"Stalnikowicz","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib118","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0953-6205(01)00152-2","article-title":"Arthritis as a rare side effect of phenytoin therapy","volume":"12","author":"Carfagna","year":"2001","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/039463200001300108","article-title":"Carbamazepine-induced hypersensitivity syndrome in a child with epilepsy","volume":"13","author":"Verrotti","year":"2000","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib120","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1001\/jama.236.24.2773","article-title":"Reversible renal failure and myositis caused by phenytoin hypersensitivity","volume":"236","author":"Michael","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib121","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/WNL.33.6.790","article-title":"Myopathy and hypersensitivity to phenytoin","volume":"33","author":"Harney","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib122","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1542\/peds.78.4.581","article-title":"Graft versus host-like illness in a child with phenobarbital hypersensitivity","volume":"78","author":"Knutsen","year":"1986","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib123","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1992.8","article-title":"Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides","volume":"51","author":"Gupta","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib124","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archderm.132.11.1315","article-title":"Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities","volume":"132","author":"Callot","year":"1996","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib125","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2133.2003.05305.x","article-title":"Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome","volume":"148","author":"Choi","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"8","author":"Ghislain","year":"2002","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib127","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","article-title":"Management of drug eruption with eosinophilia and systemic symptoms (DRESS syndrome): an update","volume":"206","author":"Tas","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib128","series-title":"Die Serumkrankheit","author":"von Pirquet","year":"1905"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib129","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1086\/374932","article-title":"Serum sickness\u2013like reaction possibly associated with meropenem use","volume":"36","author":"Ralph","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)63308-X","article-title":"Severe serum sickness\u2013like reaction to oral penicillin drugs: three case reports","volume":"86","author":"Tatum","year":"2001","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib131","first-page":"123","article-title":"Serum sickness like illness and antimicrobials in children","volume":"108","author":"Martin","year":"1995","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib132","first-page":"123","article-title":"Serum sickness\u2013like illness associated with rifampicin","volume":"73","author":"Parra","year":"1994","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1754.2003.00267.x","article-title":"Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness\u2013like reactions","volume":"39","author":"King","year":"2003","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib134","first-page":"197","article-title":"Selection of treatment of cefaclor-associated urticarial, serum sickness\u2013like reactions and erythema multiforme by emergency pediatricians: lack of a uniform standard of care","volume":"6","author":"Joubert","year":"1999","journal-title":"Can J. Clin. Pharmacol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib135","first-page":"539","article-title":"New warning about cefaclor and serum sickness in children","volume":"28","author":"Phillips","year":"1999","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib136","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/106002809202600708","article-title":"Cefaclor-associated serum sickness\u2013like disease: eight cases and review of the literature","volume":"26","author":"Vial","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib137","first-page":"395","article-title":"Serum sickness\u2013like reactions","volume":"69","author":"Yerushalmi","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib138","first-page":"100","article-title":"Is serum sickness an uncommon adverse effect of minocycline treatment?","volume":"137","author":"Malakar","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib139","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1468-3083.2000.00007-3.x","article-title":"Minocycline-induced serum sickness\u2013like reaction","volume":"14","author":"Landau","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes: an overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib141","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0248-8663(02)00017-6","article-title":"Cyclines and acne: pay attention to adverse drug reactions! A recent literature review","volume":"24","author":"Grasset","year":"2003","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib142","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/106002809703100723","article-title":"Fluoxetine-induced serum sickness\u2013like reaction","volume":"31","author":"Shapiro","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib143","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1176\/ajp.148.11.1602","article-title":"Serum sickness induced by fluoxetine","volume":"148","author":"Vincent","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib144","first-page":"68","article-title":"Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness","volume":"166","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1345\/aph.19297","article-title":"Bupropion-induced serum sickness\u2013like reaction","volume":"34","author":"McCollom","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib146","first-page":"170","article-title":"Skin manifestations of a case of phenylbutazone-induced serum sickness\u2013like reactions","volume":"10","author":"Sanchez","year":"2000","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib147","first-page":"845","article-title":"Sulfasalazine for the management of juvenile rheumatoid arthritis","volume":"28","author":"Brooks","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib148","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.10127","article-title":"Rituximab-induced serum sickness","volume":"70","author":"Herishanu","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib149","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005792-198801000-00003","article-title":"Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure","volume":"67","author":"Bielory","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/j.1875-9114.1997.tb03692.x","article-title":"Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease","volume":"17","author":"Andersen","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib151","series-title":"Clinical immunology principles and practice","first-page":"1062","article-title":"Serum sickness and pathophysiology of immune complexes","author":"Mannik","year":"1996"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib152","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1398-9995.1997.tb01017.x","article-title":"Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey","volume":"52","author":"Hunziker","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib153","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib154","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2340\/0001555574292294","article-title":"Cutaneous reactions to drugs: a series of in-patients during a five-year period","volume":"74","author":"Stubb","year":"1994","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-3083.2000.00159-5.x","article-title":"Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital","volume":"14","author":"Apaydin","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib156","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2133.1998.02313.x","article-title":"The use of skin testing in the investigation of cutaneous adverse drug reactions","volume":"139","author":"Barbaud","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib157","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1525-1470.1995.tb00149.x","article-title":"Clinical pattern of cutaneous drug eruption among children and adolescents in north India","volume":"12","author":"Sharma","year":"1995","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib158","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-4362.1998.00378.x","article-title":"Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital","volume":"37","author":"Puavilai","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib159","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2125.1999.00096.x","article-title":"Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions","volume":"48","author":"Naldi","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib160","first-page":"765","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib161","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199106203242506","article-title":"Anaphylaxis","volume":"324","author":"Bochner","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib162","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1081\/IPH-100108604","article-title":"Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients","volume":"23","author":"Nettis","year":"2001","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02991107","article-title":"Penicillin allergy","volume":"4","author":"Erffmeyer","year":"1986","journal-title":"Clin. Rev. Allergy"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib164","first-page":"159","article-title":"Nature and extent of penicillin side-reactions, with particular reference to fatalities from anapylactic shock","volume":"38","author":"Idsoe","year":"1968","journal-title":"Bull. WHO"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib165","first-page":"1308","article-title":"Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.06.012_bib166","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archderm.120.4.484","article-title":"Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice","volume":"120","author":"Ekenstam","year":"1984","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib167","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archderm.121.2.220","article-title":"Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases","volume":"121","author":"Sanchez","year":"1985","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib168","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clindermatol.2004.06.012_bib169","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T12:00:27Z","timestamp":1706097627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X04001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0738081X04001129"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2004.06.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}